Nutrient-enriched formula versus standard formula for preterm infants following hospital discharge

Lauren Young1, Nicholas D Embleton2, William McGuire3

  • 1Paediatric Intensive Care Unit, Birmingham Children's Hospital, Steelhouse Lane, Birmingham, West Midlands, UK, B4 6NH.

Insights

Nutrient-enriched formulas may enhance growth in preterm infants after hospital discharge. Preterm formula, but not postdischarge formula, showed increased growth rates, though neurodevelopmental outcomes were not significantly different.

Area of Science:

  • Neonatal nutrition
  • Pediatric growth and development
  • Evidence-based medicine

Background:

  • Preterm infants often experience growth restriction post-hospital discharge.
  • Nutrient-enriched formulas may promote catch-up growth and improve development in these infants.

Purpose of the Study:

  • To compare the efficacy of nutrient-enriched formula versus standard formula for growth and development in preterm infants post-discharge.

Main Methods:

  • Systematic review and meta-analysis of randomized and quasi-randomized controlled trials.
  • Searched multiple databases including Cochrane Library, MEDLINE, Embase, and CINAHL.
  • Assessed trial eligibility, risk of bias, and quality of evidence using GRADE approach.

Main Results:

  • Postdischarge formula (74 kcal/100 mL) did not show consistent effects on growth parameters compared to standard term formula (67 kcal/100 mL).
  • Preterm formula (80 kcal/100 mL) demonstrated increased growth rates (weight, length, head circumference) up to 18 months post-term.
  • Moderate quality evidence indicated inconsistency for postdischarge formula and imprecision for preterm formula.
  • Limited trials assessing neurodevelopmental outcomes found no significant differences at 18 months post-term.

Conclusions:

  • Evidence does not support prescribing postdischarge formula for preterm infants after hospital discharge.
  • Limited evidence suggests preterm formula may enhance growth rates up to 18 months post-term.
  • Further research is needed for long-term growth and neurodevelopmental outcomes.
Abstract

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
1.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
645
Discharge Summary Forms01:31

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
1.3K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
605
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
411
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
565